LONG ACTING GLP-1/GIP DUAL AGONISTS

The present invention relates to long acting glucagon-like peptide-1 and human glucose-dependent insulinotropic polypeptide (GIP) agonist polypeptides which may be useful for treating type 2 diabetes mellitus (T2D), diabetes with obesity, obesity and hyperlipidemia.

Saved in:
Bibliographic Details
Main Authors SONI, Krunal Harishbhai, JIVANI, Chandulal Thakarshibhai, TIWARI, Abhishek, BURADE, Vinod Sampatrao, GANDHI, Manish Harendraprasad, JOSHI, Dhiren Rameshchandra, NATARAJAN, Muthukumaran, THENNATI, Rajamannar
Format Patent
LanguageEnglish
Published 03.08.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to long acting glucagon-like peptide-1 and human glucose-dependent insulinotropic polypeptide (GIP) agonist polypeptides which may be useful for treating type 2 diabetes mellitus (T2D), diabetes with obesity, obesity and hyperlipidemia.
Bibliography:Application Number: US202118002478